HealthEquity's high P/S ratio could possibly be due to market expectations for future growth. The current justification for the high ratio lies on the low chance of decreased revenues, which investors expect to uphold share price.
Despite expenses reducing earnings last year, HealthEquity's future outlook remains positive. Unusual items don't typically recur, suggesting underestimated earning potential. The firm returned to profitability this year.
Despite HealthEquity's revenue growth and share price rise over three years, short-term underperformance and negative five-year returns are concerning. Fundamental improvements are required for shareholder confidence. Analyst forecasts could shed light on the company's future.
CraCra665 :
I go for the underdog. in most cases. I mean what I feel is right of course. I'm not goin to buy another couch when I have one. that being said ima spread it our but. I'm not gettin in when it's at a peak like that. just me tho.
HealthEquity股票讨论区
📊⚡️📊
2024上半年营收增长18.5%,营业利润则受成本和费用增速放缓的影响增长到0.53亿,净利润增长到0.15亿。
目前市值达到64.3亿,即使今年净利润达到1亿,市盈率仍有64倍,估值没什么吸引力。
• $柯尔百货(KSS.US)$ +10.4% (Board of Directors enters into three-week exclusive negotiations with $Franchise(FRG.US)$)
• $Gitlab(GTLB.US)$ +8.5% (In reaction to earnings)
• $联合原生态食品(UNFI.US)$ +6.9% (In reaction to earnings)
• $Dave & Buster's Entertainment(PLAY.US)$ +6.3% (In reaction to earnings)
• $G-III服装集团(GIII.US)$ +5.6% (In reaction to earnings)
• $HealthEquity(HQY.US)$ +4.2% (In reaction to ea...
• $ChampionX(CHX.US)$: Piper Sandler Upgrades to Overweight From Neutral - PT $30 (from $28)
• $CatchMark Timber Trust Inc(CTT.US)$: Baird Upgrades to Outperform from Neutral - PT $10 (from $9)
• $EPAM Systems(EPAM.US)$: Wolfe Research Upgrades to Outperform from Peerperform - PT $390 (from $550)
• $Essent(ESNT.US)$: JPMorgan Upgrades to Overweight from Neutral - PT $47 (from $54)
• $捷蓝航空(JBLU.US)$: MKM Partners Upgrades to Neutral from Sell...
• $Beacon Roofing Supply(BECN.US)$: JPMorgan Upgrades to Neutral from Underweight - PT $68
• $HF Sinclair(DINO.US)$ : Goldman Sachs Upgrades to Neutral from Sell - PT $43 (from $32)
• $Freshpet(FRPT.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $136
• $HealthEquity(HQY.US)$ : BTIG Upgrades to Buy from Neutral - PT $85
• $美国豪斯特酒店(HST.US)$ : Jefferies Upgrades to Buy from Hold - PT $25 (from $20)
• $马斯科(MAS.US)$ : JPMorgan...
暂无评论